期刊文献+

Rab17蛋白影响HepG2细胞增殖的研究

Effect of Rab17 on the proliferation of HepG2 cells
下载PDF
导出
摘要 目的以人肝癌细胞HepG2为研究模型,探讨Rab17蛋白对其细胞增殖的影响。方法通过Western blot技术检测永生化肝细胞系(LO2)和肝癌细胞系(HepG2、SMMC-7721、Bel-7402)中Rab17的蛋白表达水平,再分别将靶向Rab17的小干扰RNA和Rab17过表达质粒转染于HepG2中,观察二者对HepG2细胞增殖以及其相关周期蛋白C-myc、Cyclin D1表达的影响。结果 Western blot结果表明,与永生化细胞系相比较,肝癌细胞系中Rab17表达水平显著降低。在HepG2中沉默Rab17的表达,可以增加周期蛋白C-myc和Cyclin D1的表达,促进其细胞增殖,而过表达Rab17则表现为对HepG2增殖的抑制作用。结论肝癌细胞中Rab17的蛋白表达水平明显低于永生化肝细胞,上调其表达对肝癌细胞的增殖有抑制作用。 Objective To study the effect of Rab17 protein on proliferation of human hepatocarcinoma cell HepG2.Methods The protein expression levels of Rab17 in different hepatic cell lines (L02,HepG2,SMMC-7721,Bel-7402)were detected by Westem blot.Small interfering RNA targeting Rab17 and Rab17 overexpression plasmid were transfeeted into HepG2,respectively, and their effects on HepG2 ce/1 proliferation and the expression of related periodic proteins C-myc and CyclinDi were observed.Results Western blot showed that compared with normal hepatocytes,the expression level of Rab17 in hepatocellular carcinoma cells was significantly decreased.Silencing the expression of Rab17 in HepG2 can increase the expression of periodic protein and promote the proliferation of liver cancer cells,while overexpression of Rab17 can inhibit the proliferation of HepG2.Conclusion The protein expression level of Rab17 in hepatocellular carcinoma cells was significant2y lower than that of normal hepatocytes,and its up-regulated expression had an inhibitory effect on the proliferation of hepatocellular carcinoma cells.
作者 占书箱 李俊 ZHAN Shu-xiang;LI Jun(Dept of Pharmacy,The First Affiliated Hospital of Anhui Medical University,Hefei 230022,China;School of Pharmacy,Anhui Medical University,Hefei 230032,China)
出处 《肝胆外科杂志》 2018年第6期464-466,共3页 Journal of Hepatobiliary Surgery
基金 国家自然科学基金资助项目(项目编号:81770609)
关键词 Rab17 细胞增殖 HEPG2 Rab17 cell proliferation HepG2
  • 相关文献

参考文献3

二级参考文献15

  • 1Zhi-JunZeng Lian-YueYang XiangDing WeiWang.Expressions of cysteine-rich61,connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance[J].World Journal of Gastroenterology,2004,10(23):3414-3418. 被引量:28
  • 2Hemandez-Cea V, Friedman S L. Pathogenesis of liver fibrosis[J].Annu Rev Pathol, 2011,6: 425 -56.
  • 3Zheng Y, Collins S L, Lutz M A, et al. A role for mammalian target of rapamycin in regulating T cell activation versus anergy[J].J Immunol, 2007, 178 (4) : 2163 -70.
  • 4Fang L, Zhan S, Huang C, et al. TRPM7 channel regulates PDCF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways[J]. Toxicol Appl Pharmacol, 2013, 272(3): 713 - 25.
  • 5Velagapudi C, Bhandari B S, Abboud-Wemer S, et al. The tuberinimTOR pathway promotes apoptosis of tubular epithelial cells in diabetes[J].J Am Soc Nephrol, 2011, 22 (2) : 262 - 73.
  • 6Tao H, Huang C, YangJ J, et al. MeCP2 controls the expression of RASALJ in the hepatic fibrosis in rats[J]. Toxicology, 2011, 290 (2 - 3) : 327 - 33.
  • 7Buck M, Chojkier M A. Ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis[J]. PLoS One, 2007, 2(12): eI372.
  • 8Zhan H X, Cong L, Zhao Y P, et al. Activated mTORlP70S6K signaling pathway is involved in insulinoma tumorigenesis[J].J Surg Oncol, 2012, 106(8): 972 -80.
  • 9Leal P, Carcia P, Sandoval A, et al. A KT I mTO R substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and celllines[J]. Onco Targets Ther, 2013, 6: 1373 -84.
  • 10Nawroth R, Stellwagen F, Schulz W A, et al. S6KI and 4E-BPI are independent regulated and control cellular growth in bladder oancer[J] . PLoS One, 2011, 6 (11) : e27509.

共引文献387

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部